These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17413905)

  • 41. Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study.
    van Dunné FM; de Craen AJ; Heijmans BT; Helmerhorst FM; Westendorp RG
    Hum Reprod; 2006 Apr; 21(4):967-71. PubMed ID: 16439508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.
    Bakaeen F; Rice D; Correa AM; Walsh GL; Vaporciyan AA; Putnam JB; Swisher SG; Roth JA; Huh J; Chu D; Smythe WR
    Ann Thorac Surg; 2007 Sep; 84(3):982-6. PubMed ID: 17720413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
    Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
    Parvizi R; Azarfarin R; Hassanzadeh S
    Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery.
    Biancari F; Rimpiläinen R
    Heart; 2009 Jun; 95(12):964-9. PubMed ID: 19342377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin.
    Ouattara A; Bouzguenda H; Le Manach Y; Léger P; Mercadier A; Leprince P; Bonnet N; Montalescot G; Riou B; Coriat P
    Eur Heart J; 2007 Apr; 28(8):1025-32. PubMed ID: 17431000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current methods to reduce the adverse haematological consequences of cardiopulmonary bypass.
    John LC; Deverall PB
    Br J Clin Pract; 1996 Jun; 50(4):203-6. PubMed ID: 8759566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization.
    Strouch ZY; Drum ML; Chaney MA
    J Clin Anesth; 2009 Nov; 21(7):502-7. PubMed ID: 20006258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
    Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
    Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia.
    Morimoto N; Morimoto K; Morimoto Y; Takahashi H; Asano M; Matsumori M; Okada K; Okita Y
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):798-804. PubMed ID: 18722781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation.
    Balsara KR; Morozowich ST; Lin SS; Davis RD; Phillips-Bute BG; Hartwig M; Appel JZ; Welsby IJ
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):45-8. PubMed ID: 18669527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of aprotinin in children undergoing operative repair of isolated atrial septal defects.
    Chiravuri SD; Voepel-Lewis T; Devaney EJ; Malviya S
    Paediatr Anaesth; 2008 Feb; 18(2):145-50. PubMed ID: 18184246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.
    Veres G; Radovits T; Schultz H; Lin LN; Hütter J; Weigang E; Szabolcs Z; Szabó G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):340-5. PubMed ID: 17500000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of the factor V Leiden paradox.
    van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.